Annual Total Liabilities:
$71.53M+$50.04M(+232.80%)Summary
- As of today, PTGX annual total liabilities is $71.53 million, with the most recent change of +$50.04 million (+232.80%) on December 31, 2024.
- During the last 3 years, PTGX annual total liabilities has risen by +$23.86 million (+50.05%).
- PTGX annual total liabilities is now -6.15% below its all-time high of $76.22 million, reached on December 31, 2019.
Performance
PTGX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$56.25M+$6.26M(+12.53%)Summary
- As of today, PTGX quarterly total liabilities is $56.25 million, with the most recent change of +$6.26 million (+12.53%) on September 30, 2025.
- Over the past year, PTGX quarterly total liabilities has dropped by -$15.69 million (-21.81%).
- PTGX quarterly total liabilities is now -26.20% below its all-time high of $76.22 million, reached on December 31, 2019.
Performance
PTGX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PTGX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +232.8% | -21.8% |
| 3Y3 Years | +50.0% | +45.9% |
| 5Y5 Years | -6.2% | +17.9% |
PTGX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +232.8% | -23.3% | +161.7% |
| 5Y | 5-Year | -6.2% | +232.8% | -23.3% | +161.7% |
| All-Time | All-Time | -6.2% | +2914.5% | -26.2% | +1268.6% |
PTGX Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $56.25M(+12.5%) |
| Jun 2025 | - | $49.99M(-5.8%) |
| Mar 2025 | - | $53.08M(-25.8%) |
| Dec 2024 | $71.53M(+232.8%) | $71.53M(-0.6%) |
| Sep 2024 | - | $71.94M(-1.9%) |
| Jun 2024 | - | $73.31M(+6.5%) |
| Mar 2024 | - | $68.83M(+220.2%) |
| Dec 2023 | $21.50M(-33.5%) | $21.50M(-22.9%) |
| Sep 2023 | - | $27.87M(+5.6%) |
| Jun 2023 | - | $26.40M(+11.4%) |
| Mar 2023 | - | $23.69M(-26.7%) |
| Dec 2022 | $32.32M(-32.2%) | $32.32M(-16.2%) |
| Sep 2022 | - | $38.56M(-9.3%) |
| Jun 2022 | - | $42.53M(-8.6%) |
| Mar 2022 | - | $46.52M(-2.4%) |
| Dec 2021 | $47.67M(+3.9%) | $47.67M(+9.6%) |
| Sep 2021 | - | $43.52M(-7.0%) |
| Jun 2021 | - | $46.78M(+20.8%) |
| Mar 2021 | - | $38.74M(-15.6%) |
| Dec 2020 | $45.90M | $45.90M(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $47.73M(-17.0%) |
| Jun 2020 | - | $57.49M(-20.4%) |
| Mar 2020 | - | $72.23M(-5.2%) |
| Dec 2019 | $76.22M(+182.8%) | $76.22M(+28.6%) |
| Sep 2019 | - | $59.27M(-7.1%) |
| Jun 2019 | - | $63.79M(+103.0%) |
| Mar 2019 | - | $31.42M(+16.6%) |
| Dec 2018 | $26.96M(-37.5%) | $26.96M(+8.3%) |
| Sep 2018 | - | $24.90M(-16.5%) |
| Jun 2018 | - | $29.81M(-13.9%) |
| Mar 2018 | - | $34.62M(-19.7%) |
| Dec 2017 | $43.10M(+569.8%) | $43.10M(-18.0%) |
| Sep 2017 | - | $52.58M(+456.5%) |
| Jun 2017 | - | $9.45M(+21.5%) |
| Mar 2017 | - | $7.78M(+20.9%) |
| Dec 2016 | $6.43M(+22.6%) | $6.43M(+20.3%) |
| Sep 2016 | - | $5.35M(+30.1%) |
| Jun 2016 | - | $4.11M(-24.9%) |
| Mar 2016 | - | $5.47M(+4.3%) |
| Dec 2015 | $5.25M(+121.2%) | $5.25M |
| Dec 2014 | $2.37M | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Protagonist Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of PTGX is $71.53M
What is the all-time high annual total liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual total liabilities is $76.22M
What is Protagonist Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, PTGX annual total liabilities has changed by +$50.04M (+232.80%)
What is Protagonist Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of PTGX is $56.25M
What is the all-time high quarterly total liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly total liabilities is $76.22M
What is Protagonist Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, PTGX quarterly total liabilities has changed by -$15.69M (-21.81%)